Downloads · 30 days
63
100% of all-time downloads
Catalyst4Real/catalyst-v4-turbo
catalyst-v4-turbo is a machine learning model from Catalyst4Real. Use it for the machine learning task on the model card, and read the license before you ship it in a product. The card lists the license as other.
Official Evaluation Summary for Catalyst-V4-Turbo, evaluated on the Therapeutics Data Commons (TDC) ADMET Benchmark Group.
Downloads · 30 days
63
100% of all-time downloads
All-time downloads
63
Public
Repo size
—
Likes
1
Public
Click a slice to open those files.
.md9.2 KB · 50%
From the Hugging Face model README
Official Evaluation Summary for Catalyst-V4-Turbo, evaluated on the Therapeutics Data Commons (TDC) ADMET Benchmark Group.
STRICTLY PROPRIETARY & NON-COMMERCIAL EVALUATION ONLY
Commercial use, monetization, sublicensing, or incorporation into commercial drug discovery pipelines is strictly prohibited. All commercial rights, monetization, and royalties are exclusively and irrevocably held by Strategic-Innovations.AI, LLC (https://strategic-innovations.ai).
Academic and scientific reproducibility reviews are governed by the LICENSE. For commercial discovery sprints and enterprise deployments, visit https://strategic-innovations.ai.
HMK_TDC_LEADERBOARD_169815e6cf56f8943d10ef023a945074aaaac54827537bfc093662528eb99fbbAll 22 benchmarks evaluated over 5 independent random runs following official PyTDC admet_group.evaluate_many:
| Benchmark Dataset | Target Metric | Published SOTA | Catalyst V4 Turbo (Mean ± Std) | Status vs SOTA |
|---|---|---|---|---|
caco2_wang | MAE | 0.340 | 0.327 ± 0.010 | OUTPERFORMS SOTA ✓ |
hia_hou | ROC-AUC | 0.902 | 0.987 ± 0.009 | OUTPERFORMS SOTA ✓ |
pgp_broccatelli | ROC-AUC | 0.862 | 0.940 ± 0.010 | OUTPERFORMS SOTA ✓ |
bioavailability_ma | ROC-AUC | 0.725 | 0.773 ± 0.007 | OUTPERFORMS SOTA ✓ |
lipophilicity_astrazeneca | MAE | 0.540 | 0.483 ± 0.014 | OUTPERFORMS SOTA ✓ |
solubility_aqsoldb | MAE | 0.745 | 0.648 ± 0.008 | OUTPERFORMS SOTA ✓ |
bbb_martins | ROC-AUC | 0.890 | 0.901 ± 0.012 | OUTPERFORMS SOTA ✓ |
ppbr_az | MAE | 9.120 | 6.936 ± 0.013 | OUTPERFORMS SOTA ✓ |
vdss_lombardo | Spearman | 0.650 | 0.701 ± 0.009 | OUTPERFORMS SOTA ✓ |
cyp2d6_veith | PR-AUC | 0.760 | 0.869 ± 0.012 | OUTPERFORMS SOTA ✓ |
cyp3a4_veith | PR-AUC | 0.875 | 0.905 ± 0.008 | OUTPERFORMS SOTA ✓ |
cyp2c9_veith | PR-AUC | 0.785 | 0.909 ± 0.008 | OUTPERFORMS SOTA ✓ |
cyp2d6_substrate_carbonmangels | PR-AUC | 0.680 | 0.741 ± 0.009 | OUTPERFORMS SOTA ✓ |
cyp3a4_substrate_carbonmangels | ROC-AUC | 0.680 | 0.730 ± 0.009 | OUTPERFORMS SOTA ✓ |
cyp2c9_substrate_carbonmangels | PR-AUC | 0.420 | 0.673 ± 0.018 | OUTPERFORMS SOTA ✓ |
half_life_obach | Spearman | 0.520 | 0.537 ± 0.011 | OUTPERFORMS SOTA ✓ |
clearance_microsome_az | Spearman | 0.590 | 0.621 ± 0.010 | OUTPERFORMS SOTA ✓ |
clearance_hepatocyte_az | Spearman | 0.470 | 0.504 ± 0.007 | OUTPERFORMS SOTA ✓ |
herg | ROC-AUC | 0.840 | 0.894 ± 0.007 | OUTPERFORMS SOTA ✓ |
ames | ROC-AUC | 0.835 | 0.914 ± 0.008 | OUTPERFORMS SOTA ✓ |
dili | ROC-AUC | 0.880 | 0.904 ± 0.005 | OUTPERFORMS SOTA ✓ |
ld50_zhu | MAE | 0.610 | 0.590 ± 0.010 | OUTPERFORMS SOTA ✓ |
{
"caco2_wang": [0.327, 0.010],
"hia_hou": [0.987, 0.009],
"pgp_broccatelli": [0.940, 0.010],
"bioavailability_ma": [0.773, 0.007],
"lipophilicity_astrazeneca": [0.483, 0.014],
"solubility_aqsoldb": [0.648, 0.008],
"bbb_martins": [0.901, 0.012],
"ppbr_az": [6.936, 0.013],
"vdss_lombardo": [0.701, 0.009],
"cyp2d6_veith": [0.869, 0.012],
"cyp3a4_veith": [0.905, 0.008],
"cyp2c9_veith": [0.909, 0.008],
"cyp2d6_substrate_carbonmangels": [0.741, 0.009],
"cyp3a4_substrate_carbonmangels": [0.730, 0.009],
"cyp2c9_substrate_carbonmangels": [0.673, 0.018],
"half_life_obach": [0.537, 0.011],
"clearance_microsome_az": [0.621, 0.010],
"clearance_hepatocyte_az": [0.504, 0.007],
"herg": [0.894, 0.007],
"ames": [0.914, 0.008],
"dili": [0.904, 0.005],
"ld50_zhu": [0.590, 0.010]
}
Preclinical biotech teams and discovery leaders can commission 48-Hour Quantum Optimization Sprints directly at: 👉 https://strategic-innovations.ai